LifeBond
LifeBond, a 2016 Frost & Sullivan 2016 European New Product Innovation Award winner, is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair intended to improve patient outcomes and support the body's natural healing process. The company's devices have the potential to fill a long list of unmet surgical needs. LifeBond's LifeSeal ® surgical sealant is designed to provide staple-line reinforcement in GI surgery. Reducing leakage has the potential to save patient lives, improve patient recovery, and avoid re-admissions and repeated surgeries. LifeSeal ® has a CE marking for sale in the European Union (EU). In the US, LifeSeal ® is available only for use as experimental device in the approved IDE study. LifeBond's LifeMesh ™ , a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeMesh ™ is an investigational device and has not yet been approved for sale in the US or in any other market.
About LifeBond
Founded
2007Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$57MCategory
Industry
Medical DevicesLocation
City
Wallis and FutunaState
Wallis and FutunaCountry
IsraelLifeBond
Find your buyer within LifeBond